Skip to Content

Inspire Medical Systems Inc INSP

Morningstar Rating
$221.90 −0.94 (0.42%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INSP is trading at a 23% discount.
Price
$222.28
Fair Value
$778.15
Uncertainty
Very High
1-Star Price
$995.63
5-Star Price
$665.44
Economic Moat
Jfwp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INSP is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$222.84
Day Range
$218.99224.99
52-Week Range
$123.29329.86
Bid/Ask
$221.78 / $222.10
Market Cap
$6.72 Bil
Volume/Avg
197,895 / 489,647

Key Statistics

Price/Earnings (Normalized)
159.79
Price/Sales
11.27
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
1,011

Comparables

Valuation

Metric
INSP
SIBN
ZIMV
Price/Earnings (Normalized)
159.7910.41
Price/Book Value
12.403.931.12
Price/Sales
11.274.520.98
Price/Cash Flow
107.5813.21
Price/Earnings
INSP
SIBN
ZIMV

Financial Strength

Metric
INSP
SIBN
ZIMV
Quick Ratio
7.058.010.84
Current Ratio
7.609.012.78
Interest Coverage
−13.52−1.51
Quick Ratio
INSP
SIBN
ZIMV

Profitability

Metric
INSP
SIBN
ZIMV
Return on Assets (Normalized)
7.16%−8.97%14.12%
Return on Equity (Normalized)
8.31%−12.61%31.63%
Return on Invested Capital (Normalized)
5.07%−11.78%18.79%
Return on Assets
INSP
SIBN
ZIMV
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesFcjktwngVjprgd$188.9 Bil
SYK
Stryker CorpCdgdsfchlMqpb$129.0 Bil
MDT
Medtronic PLCLfhkzncfKvkfk$106.5 Bil
BSX
Boston Scientific CorpCvvzbjzHfcqyw$100.9 Bil
EW
Edwards Lifesciences CorpQjnvyghlhLtyvwqz$53.7 Bil
DXCM
DexCom IncFrzhzqdnvBbc$51.9 Bil
ZBH
Zimmer Biomet Holdings IncNslbhzvlZcrq$25.5 Bil
ALGN
Align Technology IncFyqnhcjcyRylwx$24.7 Bil
PHG
Koninklijke Philips NV ADRPdnpbwlbnPykgchr$18.7 Bil
PODD
Insulet CorpPkvxjbfdqdYycqhcd$12.3 Bil

Sponsor Center